NEW YORK , Sept. 18, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape- The global amniotic membrane market size is estimated to grow by USD 2.7 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of about 15.19% during the forecast period. Extensive use of amniotic membrane transplantation in ophthalmic surgeries is driving market growth, with a trend towards growing reimbursement coverage for new products.
However, limited supply of amniotic membranes poses a challenge. Key market players include Amnio Technology LLC, Applied Biologics LLC, BIOHEALING SRO, Celularity Inc., Flower Orthopedics Corp.
, Human Regenerative Technologies LLC, Integra Lifesciences Corp., Katena Products Inc., Merakris Therapeutics Inc.
, MiMedx Group Inc., Next Biosciences Pty Ltd., NuVision Biotherapies Ltd, Organogenesis Holdings Inc.
, Orthofix Medical Inc., Reea carewell products, Skye Biologics Holdings LLC, Stryker Corp., Surgenex LLC, SURGITECH INNOVATION, and TissueTech Inc.
. AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View your snapshot now Key Market Trends Fueling Growth The global amniotic membrane market is experiencing significant changes due to government initiatives to provide value-based care and cover newly introduced healthcare products.
Amniotic membranes, being tissue-engineered products, come with considerable costs related.